UCBChief of Staff Europe - Head of Commercial Operations - Rare & Neurology Disease Organization
Aug. 2022 - Dec. 2024Brussels Region, Belgium-Owned pan-EU launch readiness for gMG (generalized myasthenia gravis) and TK2D (thymidine kinase 2 deficiency), coordinating Medical Affairs, Market Access/HTA, Regulatory, HEOR, Supply, and Commercial across 27 countries. - Being the right hand to the EU business unit head (strategic planning, financial and FTE planning and management, team management, early access program, supply chain, access, and medical integration).